论文部分内容阅读
目的:探讨米非司酮配伍米索前列醇联合清宫术终止瘢痕子宫妊娠的疗效和安全性。方法:选取我院在2014年7月至2016年4月收治的62例瘢痕子宫妊娠孕妇,采用自由分组法将其分为研究组和对照组,每组患者人数为31例。研究组给予米非司酮与米索前列醇联合治疗,并在妊娠物排出后采用清宫术,对照组行常规流产手术。观察比较两组的流产情况与相关指标等。结果:观察组患者的总有效率明显高于对照组患者,差异有统计学意义(P<0.05);观察组患者的妊娠物排出时间和阴道出现量明显优于对照组患者,差异有统计学意义(P<0.05)。结论:瘢痕子宫终止妊娠采用米非司酮与米索前列醇联合清宫术,具有良好的流产效果,且安全可靠,临床应用价值高。
Objective: To investigate the efficacy and safety of mifepristone combined with misoprostol combined with cesarean termination of uterine scar pregnancy. Methods: Totally 62 pregnant women with uterine scar were treated in our hospital from July 2014 to April 2016. The pregnant women were divided into study group and control group by free grouping method. The number of each group was 31 cases. The study group was given mifepristone and misoprostol combined treatment, and in the pregnancy after the removal of the use of curettage, the control group underwent routine abortion. Observation and comparison of abortion status and related indexes in the two groups. Results: The total effective rate in the observation group was significantly higher than that in the control group (P <0.05). The discharge time and the amount of vaginal discharge in the observation group were significantly better than those in the control group Significance (P <0.05). Conclusion: The use of mifepristone combined with misoprostol in the termination of uterine scar pregnancy has a good effect of abortion and is safe, reliable and of high clinical value.